Overview
- 12 FDA inspections are on record.
- 8 inspections produced a Form 483.
- The most recent recorded inspection date is 2023-06-29.
At a glance
Inspections
12
Form 483s
8
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 21 Jun 2023 – 29 Jun 2023 | Human Drugs | Clean | |
| 20 Nov 2020 – 2 Dec 2020 | Human Drugs | Clean | |
| 15 May 2017 – 24 May 2017 | Human Drugs | 483 | View 483 → |
| 22 Jun 2016 – 13 Jul 2016 | Human Drugs | 483 | View 483 → |
| 10 Aug 2015 – 19 Aug 2015 | Human Drugs | 483 | View 483 → |
| 28 Apr 2014 – 2 May 2014 | Human Drugs | Clean | |
| 11 Jul 2013 – 18 Jul 2013 | Human Drugs | 483 | View 483 → |
| 28 Jun 2011 | Not recorded | 483 | On file |
| 1 Apr 2010 | Not recorded | 483 | View 483 → |
| 12 Jun 2009 | Not recorded | 483 | On file |
| 25 Jun 2008 | Not recorded | 483 | On file |
| 24 May 2006 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
13 Jul 2016
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Katherine D Adams, Stacey S Degarmo
Investigators
FDA investigators tied to this site in the record.
Ramon E Martinez2 insp.
Cassandra L Abellard1 insp.
Holly Brevig1 insp.
Raeann R Wu1 insp.
Erik W Koester1 insp.
Jonathan G Matrisciano1 insp.
Katherine D Adams1 insp.
Stacey S Degarmo1 insp.
Arie Menachem1 insp.
Sharon K Thoma1 insp.
Katie L Korchinski1 insp.
Towanda L Terrell1 insp.
Paul L Bellamy1 insp.
Rebecca E Dombrowski1 insp.
Abdur-Rafay Shareef1 insp.
Maya M Davis1 insp.
Megan A Haggerty1 insp.
Kenneth H Williams1 insp.
Paraluman S Leonin1 insp.
Valentino Fiorella1 insp.
Ellen P Madigan1 insp.
Brenda P King1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(f) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(5) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(6) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.160(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Curia Massachusetts, Inc.'s 8 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat